Loading...

ACAD ACADIA PHARMACEUTICALS INC Legal Disputes 8-K Filing

CD P

CD

ACADIA PHARMACEUTICALS INC

(ACAD)

2025 8-K

Show Summary

Show Summary

Management Changes

Earnings Releases

Bylaw Amendments

Financial Results

Management Change

Q3 Financial Results

Financial Results Announcement

Annual Meeting Approval

Financial Results Announcement

Results of Phase 3 ADVANCE-...

Financial Results Announcement

Departure of Directors

Management Change

Financial Results Announcement

Financial Results Announcement

Financial Results Announcement

Financial Results Announcement

External Links:

On June 9, 2025, Acadia Pharmaceuticals announced that the U.S. Court of Appeals affirmed a decision confirming the validity of its NUPLAZID® patent in a case against MSN Laboratories. This ruling is significant for the company's intellectual propert

AI Assistant

ACADIA PHARMACEUTICALS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.